Physician profile
Daniel Woods
NPI 1326209347
$6,397.90
in general payments reported to CMS, 2019-2025
20 companies · $563 in 2025
The $563 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $236 · 2020: $616 · 2021: $3,914 · 2022: $400 · 2023: $410 · 2024: $259 · 2025: $563.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,232.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,231.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,114.00 | 2021 | |
| Stryker Corporation | $856.63 | 2019-2025 | Alphavent, Flexible Guide Pin (Stryker Acl Versitomic), Air |
| Medwest Associates | $791.07 | 2020-2021 | |
| Depuy Synthes Sales INC. | $747.52 | 2019-2025 | Na, Fibulink, Lcp |
| Smith+Nephew, INC. | $195.42 | 2019-2023 | Real Intelligence |
| Ferring Pharmaceuticals INC. | $158.39 | 2019-2023 | Euflexxa |
| Lightbody Medical Technologies INC | $149.97 | 2024 | |
| Pacira Therapeutics, INC. | $95.17 | 2019-2021 | |
| Ethicon US, LLC | $39.69 | 2020-2025 | Stratafix, Dermabond Prineo |
| Bioventus LLC | $36.06 | 2020-2025 | Supartz Fx Sodium Hyaluronate |
| Convatec INC. | $34.93 | 2022-2024 | |
| Abbott Laboratories | $32.14 | 2022 | |
| Zimmer Biomet Holdings, INC. | $31.35 | 2021 | |
| Orthofix Medical, INC. | $23.72 | 2019-2022 | |
| Pacira Pharmaceuticals Incorporated | $20.41 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Melinta Therapeutics, LLC | $16.65 | 2022 | |
| Linvatec Corporation | $14.36 | 2025 | Biobrace 23mm |
| Pfizer INC. | $14.18 | 2020 | |
| Organogenesis INC. | $13.90 | 2025 | Cygnus Dual |
| Zyla Life Sciences, INC. | $12.34 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Woods listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.